Compile Data Set for Download or QSAR
Report error Found 384 from Acerta Pharma
TargetTyrosine-protein kinase Blk(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50357312BDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant full length human His-tagged BLK cytoplasmic domain expressed in baculovirus expression system using tyrosine-1 peptide as ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559911BDBM50559911(CHEMBL4744536)
Affinity DataIC50: 0.150nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559913BDBM50559913(CHEMBL4763873)
Affinity DataIC50: 0.260nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559912BDBM50559912(CHEMBL4791702)
Affinity DataIC50: 0.330nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50579857BDBM50579857(CHEMBL5077776)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50357312BDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 0.430nMAssay Description:Inhibition of His-tagged recombinant human His-tagged full length BTK expressed in baculovirus expression system using Tyr01 peptide as substrate pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559922BDBM50559922(CHEMBL4759528)
Affinity DataIC50: 0.470nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559919BDBM50559919(CHEMBL4782725)
Affinity DataIC50: 0.540nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50357312BDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of His-tagged recombinant full length human His-tagged BMX cytoplasmic domain expressed in baculovirus expression system using tyrosine-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50579860BDBM50579860(CHEMBL5076067)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559914BDBM50559914(CHEMBL4792062)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50579860BDBM50579860(CHEMBL5076067)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50579857BDBM50579857(CHEMBL5077776)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559920BDBM50559920(CHEMBL4794213)
Affinity DataIC50: 0.960nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559918BDBM50559918(CHEMBL4756092)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50322823BDBM50322823((S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahy...)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50029668BDBM50029668(AZD-9291 | Osimertinib | US10085983, Compound AZD-...)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559908BDBM50559908(CHEMBL4752700)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50579862BDBM50579862(CHEMBL5079430)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50579861BDBM50579861(CHEMBL5085118)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50029668BDBM50029668(AZD-9291 | Osimertinib | US10085983, Compound AZD-...)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50579862BDBM50579862(CHEMBL5079430)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50579861BDBM50579861(CHEMBL5085118)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2023
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559921BDBM50559921(CHEMBL4755977)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of His-tagged recombinant human His-tagged full length BTK expressed in baculovirus expression system using Tyr01 peptide as substrate pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559916BDBM50559916(CHEMBL4743222)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515339BDBM515339(US11110088, Compound Table 1.13)
Affinity DataIC50: 1.5nMAssay Description:TXK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.TXK enzyme (M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515333BDBM515333(US11110088, Compound Table 1.7)
Affinity DataIC50: 1.60nMAssay Description:BTK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.BTK enzyme (H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50559921BDBM50559921(CHEMBL4755977)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lynt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515327BDBM515327(US11110088, Compound Table 1.1)
Affinity DataIC50: 1.60nMAssay Description:BTK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.BTK enzyme (H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase Tec(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515342BDBM515342(US11110088, Compound Table 1.16)
Affinity DataIC50: 1.60nMAssay Description:TEC enzyme (Millipore #14-801M), is diluted to 2 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.1% NaN3, 1 mM DTT, 2 mM MnCl2, pH ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515334BDBM515334(US11110088, Compound Table 1.8)
Affinity DataIC50: 1.70nMAssay Description:TXK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.TXK enzyme (M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515340BDBM515340(US11110088, Compound Table 1.14)
Affinity DataIC50: 1.80nMAssay Description:BTK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.BTK enzyme (H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515335BDBM515335(US11110088, Compound Table 1.9)
Affinity DataIC50: 1.80nMAssay Description:BTK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.BTK enzyme (H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515340BDBM515340(US11110088, Compound Table 1.14)
Affinity DataIC50: 1.80nMAssay Description:TXK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.TXK enzyme (M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase Tec(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50357312BDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of His-tagged recombinant human TEC expressed in baculovirus expression system preincubated for 1 hr by Z'lyte assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515340BDBM515340(US11110088, Compound Table 1.14)
Affinity DataIC50: 1.90nMAssay Description:BMX enzyme (Millipore #14-499M), is diluted to 0.5 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.1% NaN3, 1 mM DTT, 2 mM MnCl2, p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515334BDBM515334(US11110088, Compound Table 1.8)
Affinity DataIC50: 1.90nMAssay Description:BTK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.BTK enzyme (H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase Tec(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515339BDBM515339(US11110088, Compound Table 1.13)
Affinity DataIC50: 1.90nMAssay Description:TEC enzyme (Millipore #14-801M), is diluted to 2 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.1% NaN3, 1 mM DTT, 2 mM MnCl2, pH ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase Tec(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515334BDBM515334(US11110088, Compound Table 1.8)
Affinity DataIC50: 1.90nMAssay Description:TEC enzyme (Millipore #14-801M), is diluted to 2 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.1% NaN3, 1 mM DTT, 2 mM MnCl2, pH ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515327BDBM515327(US11110088, Compound Table 1.1)
Affinity DataIC50: 2nMAssay Description:TXK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.TXK enzyme (M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase Tec(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515333BDBM515333(US11110088, Compound Table 1.7)
Affinity DataIC50: 2nMAssay Description:TEC enzyme (Millipore #14-801M), is diluted to 2 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.1% NaN3, 1 mM DTT, 2 mM MnCl2, pH ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50357312BDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 2nMAssay Description:Inhibition of recombinant human N-terminal GST-tagged TXK (260 to 527 residues) expressed in baculovirus expression system using tyrosine-6 peptide a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515329BDBM515329(US11110088, Compound Table 1.3)
Affinity DataIC50: 2nMAssay Description:BTK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.BTK enzyme (H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515336BDBM515336(US11110088, Compound Table 1.10)
Affinity DataIC50: 2.10nMAssay Description:BTK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.BTK enzyme (H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515333BDBM515333(US11110088, Compound Table 1.7)
Affinity DataIC50: 2.10nMAssay Description:TXK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.TXK enzyme (M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase Tec(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515327BDBM515327(US11110088, Compound Table 1.1)
Affinity DataIC50: 2.20nMAssay Description:TEC enzyme (Millipore #14-801M), is diluted to 2 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.1% NaN3, 1 mM DTT, 2 mM MnCl2, pH ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515341BDBM515341(US11110088, Compound Table 1.15)
Affinity DataIC50: 2.20nMAssay Description:BTK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.BTK enzyme (H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515334BDBM515334(US11110088, Compound Table 1.8)
Affinity DataIC50: 2.40nMAssay Description:BMX enzyme (Millipore #14-499M), is diluted to 0.5 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.1% NaN3, 1 mM DTT, 2 mM MnCl2, p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Acerta Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 515339BDBM515339(US11110088, Compound Table 1.13)
Affinity DataIC50: 2.40nMAssay Description:BTK enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below.BTK enzyme (H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetTyrosine-protein kinase Tec(Human)
Acerta Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 515329BDBM515329(US11110088, Compound Table 1.3)
Affinity DataIC50: 2.5nMAssay Description:TEC enzyme (Millipore #14-801M), is diluted to 2 U/mL in KR buffer (10 mM Tris-HCl, 10 mM MgCl2, 0.01% Tween-20, 0.1% NaN3, 1 mM DTT, 2 mM MnCl2, pH ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

Displayed 1 to 50 (of 384 total ) | Next | Last >>
Jump to: